U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07862972) titled 'Cryoballoon Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation' on Sept. 30.
Brief Summary: This post-marketing, multi-center, prospective, single-arm, observational study will be conducted across 3 clinical sites in China and enroll no more than 50 patients with paroxysmal atrial fibrillation. After clinical site initiation, each study site was permitted to enroll up to 2 roll-in cases to allow operators to familiarize themselves with the Nordica(R) cryoballoon and standardize procedural techniques. A competitive enrollment method will be adopted to recruit up to 50 patients with paroxysmal atrial fibrillation. The Nordica(...